查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2011163

互聯醫療設備市場：2026-2032年全球市場預測（按產品類型、連接技術、最終用戶、應用和分銷管道分類）

Connected Medical Devices Market by Product Type, Connectivity Technology, End User, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，互聯醫療設備市場價值將達到 672.6 億美元，到 2026 年將成長至 822.3 億美元，到 2032 年將達到 2,913.7 億美元，複合年成長率為 23.29%。

主要市場統計數據
基準年 2025 672.6億美元
預計年份：2026年 822.3億美元
預測年份 2032 2913.7億美元
複合年成長率 (%) 23.29%

從策略角度概述了整合感測、分析和連結如何改變臨床工作流程、產品設計重點和市場進入動態。

透過整合感測、分析和連結功能，互聯醫療設備正在重塑醫療服務模式，使臨床監測超越傳統醫療環境。硬體、軟體和雲端服務的整合正在建立新的診療路徑，實現早期發現和早期療育，並推廣持續監測模式，從而縮短住院時間，改善慢性病管理。因此，醫療設備製造商、數位醫療公司和醫療服務提供者都必須將產品開發與臨床工作流程、互通性標準和網路安全框架相協調。

軟體成熟度的加速提升、連接標準的進步以及贖回模式的演變，正在重新定義競爭優勢和監管義務。

互聯醫療設備產業正經歷一系列變革，這些變革正在重新定義競爭優勢、監管預期和醫療服務模式。首先，內建軟體和人工智慧驅動的分析技術的成熟度曲線正從原型階段的實驗轉向臨床可用的功能，促使製造商採用生命週期方法進行軟體檢驗、上市後效能監測和演算法管治。因此，產品藍圖現在將臨床證據的生成和可解釋性納入其中，不再只是可選功能，而是核心商業需求。

關稅措施對互聯醫療設備相關人員的採購、產品設計和供應鏈韌性的營運和策略影響。

近期針對醫療設備原料和成品的貿易措施，給製造商和供應商在成本、採購和進度安排方面帶來了一系列複雜的壓力。關稅和報復性貿易措施的疊加，改變了零件和組件原產地認定的標準，迫使企業重新評估其供應商組合，增加庫存緩衝，並加快近岸外包和雙重採購策略的實施。這些調整對下游環節，例如前置作業時間、品管流程以及用於生產設備升級的資金配置，都產生了影響。

將產品子類別、臨床應用、最終用戶環境、連接方式和分銷管道與推動採用的因素聯繫起來進行詳細的細分分析。

精細化的市場區隔揭示了產品設計、臨床應用、終端用戶環境、連接方式和分銷策略如何影響產品的市場接受度和商業優先順序。從產品類型（診斷設備、監測設備、手術設備、治療設備和穿戴式裝置）的角度進行分析，突顯了臨床醫生和患者的細微需求。診斷設備，特別是成像系統、就地檢驗盒和超音波診斷設備，需要高診斷準確性、可靠的校準流程以及與影像存檔和通訊系統的互通性。監測設備，例如心電圖監視器、血糖監視器和生命徵象監視器，優先考慮持續的資料完整性、電源管理和警報管理，以支援臨床決策。手術醫療設備，包括電外科設備、內視鏡和機器人手術系統，需要嚴格的可靠性、與無菌環境的兼容性以及與手術室資訊系統的無縫整合。治療醫療設備，例如透析系統、輸液幫浦和人工呼吸器，則強調安全冗餘、劑量準確性和故障安全機制。穿戴式設備，例如健身追蹤器和智慧型手錶，在消費者易用性、感測器精度和無縫行動連線之間取得了良好的平衡，從而促進了持續使用。

影響美洲、歐洲、中東和非洲以及亞太市場商業化、監管策略和供應鏈選擇的區域因素。

區域趨勢對互聯醫療設備的需求促進因素、監管要求和市場推廣執行有顯著影響。在美洲，成熟的醫保報銷體系、先進的醫院基礎設施以及對遠端監測的強勁需求，使得那些能夠顯著減少急症治療需求的設備更受青睞。此外，該地區緊密的公立和私人保險公司網路，有望加速與慢性病管理和急性後期護理路徑相契合的設備推廣。同時，美洲的供應鏈物流結構以及與零件供應商的地理位置接近性，使其成為近岸外包和產品快速改進的中心。

對成熟新興企業進行策略分析，重點關注平台化、夥伴關係和基於證據的商業化：旨在擴大連網型設備的交付範圍

互聯醫療設備領域的主要企業呈現一致的趨勢：將軟體和服務整合到核心產品中，優先考慮網路安全和法規遵從性，並建立生態系統夥伴關係以擴大臨床應用範圍。市場領導者正在投資模組化平台，以實現快速功能部署和第三方整合，同時保持嚴格的變更管理流程，用於軟體更新和上市後監測。他們的研發方法也強調與臨床機構的合作、與醫療系統進行試點部署以及迭代檢驗，以增強臨床醫生的信心並建立報銷機制。

為製造商和供應商提供可操作的策略措施，以加強連網型設備產品開發、供應鏈韌性和上市時間模式。

產業領導企業應採取三管齊下的策略，將產品策略、營運韌性和市場參與相結合，從而從互聯醫療設備中創造長期價值。首先，應在產品開發的早期階段納入監管和臨床證據規劃，以確保軟體迭代、演算法更新和硬體改進在後續流程中盡可能順暢。這種積極主動的規劃能夠縮短新功能的上市時間，並在獲得結果數據後加強與支付方的溝通。

採用透明的研究途徑，結合相關人員訪談、技術評估、監管審查和情境測試，以檢驗對連網型設備。

本分析所依據的綜合研究，透過對關鍵相關人員的訪談、技術產品評估、政策和監管審查以及對二手文獻的整合，全面展現了互聯醫療設備的整體情況。與臨床醫生、採購負責人、監管專家和設備工程師的結構化訪談是主要資訊來源，這些訪談基於實際操作情況和證據需求，從而形成深刻見解。除這些對話外，還對具有代表性的設備架構、連接協定堆疊和網路安全狀況進行了技術評估，以識別反覆出現的技術限制和整合模式。

全面闡述將互聯醫療設備創新轉化為永續的臨床價值和商業性成功的系統性要求。

互聯醫療設備代表著醫療保健轉型的重要前沿領域，它為早期診斷、慢性病持續管理以及更有效率地利用臨床資源提供了途徑。先進感測技術、內建軟體和廣泛互聯的整合，對產品設計、證據產生和上市後管理提出了新的要求。能夠將臨床檢驗、網路安全和互通性與穩健的供應鏈相協調的企業，將更有利於擴大和維持其市場優勢。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 互聯醫療設備市場：依產品類型分類

  • 診斷設備
    • 醫學影像系統
    • 即時檢測套組
    • 超音波診斷設備
  • 監控設備
    • 心電圖監測儀
    • 血糖監測儀
    • 生命徵象監測
  • 手術器械
    • 電外科設備
    • 內視鏡設備
    • 機器人手術系統
  • 治療設備
    • 透析系統
    • 點滴幫浦
    • 人工呼吸器
  • 穿戴式裝置
    • 健身追蹤器
    • 智慧型手錶

第9章 互聯醫療設備市場：依連接技術分類

  • Bluetooth
  • 細胞
  • NFC
  • Wi-Fi
  • Zigbee

第10章 互聯醫療設備市場：依最終使用者分類

  • 門診部
  • 診所
  • 診斷中心
  • 居家照護環境
    • 老年護理
    • 術後護理
  • 醫院
    • 私立醫院
    • 公立醫院

第11章 互聯醫療設備市場：依應用領域分類

  • 藥物輸送
    • 靜脈輸液
    • 吸入系統
    • 注射給藥
  • 診斷影像
    • CT
    • MRI
    • 超音波影像
    • X光
  • 病患監測
    • 門診監測
    • 重症監護監測
    • 遠端監控
  • 復原
    • 神經復健
    • 職業療法
    • 物理治療
  • 手術支援
    • 導航系統
    • 機器人支援
  • 遠端醫療
    • 遠距離診斷
    • 遠端患者監護
    • 視訊諮詢

第12章 互聯醫療設備市場：依分銷管道分類

  • 離線
  • 線上

第13章 互聯醫療設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 互聯醫療設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 互聯醫療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國互聯醫療設備市場

第17章：中國互聯醫療設備市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Apple Inc.
  • Baxter International Inc.
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Dexcom Inc.
  • Fitbit Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Garmin Ltd.
  • GE Healthcare
  • Honeywell International Inc.
  • iHealth Labs Inc.
  • Insulet Corporation
  • Johnson & Johnson Services Inc.
  • Masimo Corporation
  • Medtronic plc
  • Omron Healthcare Inc.
  • Philips Healthcare
  • ResMed Inc.
  • Roche Diagnostics
  • Samsung Electronics Co. Ltd.
  • Siemens Healthineers AG
  • Smiths Medical
  • Stryker Corporation
  • Zimmer Biomet Holdings Inc.
Product Code: MRR-43750BE226AB

The Connected Medical Devices Market was valued at USD 67.26 billion in 2025 and is projected to grow to USD 82.23 billion in 2026, with a CAGR of 23.29%, reaching USD 291.37 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 67.26 billion
Estimated Year [2026] USD 82.23 billion
Forecast Year [2032] USD 291.37 billion
CAGR (%) 23.29%

A strategic overview of how integrated sensing, analytics, and connectivity are transforming clinical workflows, product design priorities, and market entry dynamics

Connected medical devices are reshaping care delivery by integrating sensing, analytics, and connectivity to extend clinical oversight beyond traditional care settings. This convergence of hardware, software, and cloud-enabled services has cultivated new care pathways, enabled earlier detection and intervention, and fostered continuous monitoring models that reduce hospital stays and improve chronic disease management. The result is a landscape in which device manufacturers, digital health companies, and care providers must synchronize product development with clinical workflows, interoperability standards, and cybersecurity postures.

Across the ecosystem, innovation is no longer confined to component improvements; it now requires systems thinking that aligns user experience, regulatory compliance, and data lifecycle management. As the clinical and commercial value of connected devices increases, organizations must confront complex trade-offs: balancing device miniaturization and battery longevity against data fidelity; reconciling the pace of software feature releases with evidence generation; and harmonizing revenue models that mix device sales with recurring services. Effective responses demand cross-functional collaboration among engineering, clinical, regulatory, and commercial teams.

Stakeholders also operate within an evolving policy and trade environment that can influence sourcing, manufacturing, and distribution decisions. Taken together, these dynamics are creating both opportunity and risk: the capacity to deliver differentiated patient outcomes at scale, and the exposure to supply chain disruption, cyber threats, and reimbursement uncertainty. This introduction sets the stage for an integrated analysis that follows, revealing the strategic inflection points organizations must address to capture long-term value from connected medical devices.

How accelerated software maturity, advanced connectivity standards, and shifting reimbursement models are redefining competitive advantage and regulatory obligations

The connected medical device landscape is undergoing a series of transformative shifts that are redefining competitive advantage, regulatory expectations, and care delivery models. First, the maturity curve of embedded software and AI-driven analytics has moved from prototype experimentation to clinically actionable features, prompting manufacturers to adopt lifecycle approaches to software validation, post-market performance monitoring, and algorithm governance. Consequently, product roadmaps now integrate clinical evidence generation and explainability as core commercial requirements rather than optional capabilities.

Second, the proliferation of low-power wide-area networks and higher-throughput cellular standards is expanding the feasible envelope for remote monitoring and telehealth integration. This connectivity evolution is enabling devices to operate in distributed care models with lower latency, richer telemetry, and greater reliability than prior generations. It also elevates the importance of interoperability-both syntactic and semantic-so that patient data can be aggregated, normalized, and acted upon across disparate health IT systems.

Third, reimbursement and procurement practices are gradually adapting to value-based paradigms, creating incentives for devices that demonstrably reduce acute care utilization and improve chronic disease outcomes. In parallel, regulatory authorities are refining guidance on software as a medical device, cybersecurity risk management, and real-world performance evidence, compelling manufacturers to embed regulatory strategy into product development cycles.

Finally, market structure is shifting as strategic partnerships between device makers, cloud providers, and clinical networks proliferate. These alliances accelerate market access but also introduce new dependencies and shared liabilities. The net effect of these shifts is a competitive landscape where agility in clinical validation, connectivity integration, and post-market stewardship distinguishes market leaders from laggards.

Operational and strategic consequences of tariff measures on sourcing, product design, and supply chain resilience for connected medical device stakeholders

Recent trade measures targeting medical device inputs and finished goods have introduced a complex set of cost, sourcing, and scheduling pressures for manufacturers and suppliers. Tariff actions, coupled with reciprocal trade responses, have changed the calculus for where components and assemblies are produced, prompting firms to reassess supplier portfolios, increase inventory buffers, and accelerate nearshoring or dual-sourcing strategies. These adjustments have downstream effects on lead times, quality control processes, and capital allocation for manufacturing upgrades.

Operationally, increased duties on specific components raise the effective landed cost of devices and can compress margins unless offset by pricing adjustments, supplier cost reductions, or moves to alternative materials. In many cases, manufacturers facing tariff exposure have pursued redesigns that substitute tariffed parts with functionally equivalent alternatives sourced from different jurisdictions. Such redesigns often entail qualification testing and updated regulatory submissions, creating timelines that extend beyond immediate commercial cycles.

Strategic responses to the tariff environment are varied. Some organizations elect to consolidate higher-value assembly within tariff-favored jurisdictions, while others build in pricing elasticity through service contracts and managed care arrangements that shift part of the cost burden. At the same time, procurement teams emphasize contract language that preserves renegotiation rights in the face of tariff escalations and encourage longer-term supply agreements to secure capacity.

Importantly, tariffs also influence innovation pathways. When component costs rise, development priorities may pivot toward higher-margin devices, software-enabled service layers, or aftermarket consumables that are less exposed to cross-border duties. Meanwhile, policy uncertainty surrounding trade measures increases the value of scenario planning and stress-testing for product portfolios, ensuring firms can preserve operational continuity and market access under alternative tariff trajectories.

In-depth segmentation analysis linking product subclasses, clinical applications, end-user environments, connectivity modalities, and distribution channels to adoption levers

Granular segmentation reveals how product design, clinical application, end-user contexts, connectivity choices, and distribution strategies shape adoption dynamics and commercial priorities. When viewed through Product Type lenses such as Diagnostic Devices, Monitoring Devices, Surgical Devices, Therapeutic Devices, and Wearable Devices, the nuanced needs of clinicians and patients emerge. Diagnostic Devices-and specifically imaging systems, point-of-care test kits, and ultrasound devices-demand high diagnostic accuracy, robust calibration workflows, and interoperability with picture archiving and communication systems. Monitoring Devices such as ECG monitors, glucose monitors, and vital signs monitors prioritize continuous data integrity, power management, and alarm management to support clinical decision-making. Surgical Devices, including electrosurgical devices, endoscopic devices, and robotic surgery systems, require exacting reliability, sterile compatibility, and seamless integration with operating room informatics. Therapeutic Devices like dialysis systems, infusion pumps, and ventilators emphasize safety redundancies, dose delivery accuracy, and fail-safe mechanisms. Wearable Devices, represented by fitness trackers and smart watches, balance consumer ergonomics, sensor fidelity, and seamless mobile connectivity to encourage sustained engagement.

Application-based segmentation further clarifies value propositions across drug delivery, imaging, patient monitoring, rehabilitation, surgical assistance, and telehealth. Within drug delivery, distinctions among infusion drug delivery, inhalation systems, and injection drug delivery influence device form factor, adherence monitoring, and connectivity to electronic medication records. Imaging modalities such as CT, MRI, ultrasound imaging, and X-ray carry distinct regulatory pathways, capital intensity, and clinician training requirements. Patient monitoring spans ambulatory monitoring, critical care monitoring, and remote monitoring, each with different signal-capture priorities, latency tolerances, and integration needs with clinical workflows. Rehabilitation applications from neurorehabilitation to occupational therapy and physical therapy leverage sensors and feedback loops to quantify outcomes and support remote care. Surgical assistance via navigation systems and robotic assistance underscores the convergence of precision mechanics, real-time imaging, and surgeon interface design. Telehealth subsegments-remote diagnosis, remote patient monitoring, and video consultation-highlight the need for seamless, secure data exchange and clear escalation pathways.

End-user segmentation across ambulatory care centers, clinics, diagnostic centers, home care settings, and hospitals shapes procurement cycles and support requirements. Home care settings, which include elderly care and post-operative care, prioritize ease of use, caregiver support, and remote clinician oversight. Hospitals, whether private or public, demand scale, service-level agreements, and evidence of clinical and economic benefit to support capital investments. Connectivity Technology choices-Bluetooth (including BLE and Classic Bluetooth), cellular standards spanning 2G through 5G, NFC, Wi-Fi (802.11ac and 802.11n), and Zigbee-determine device interoperability, power consumption, range, and security architecture. Finally, Distribution Channel differentiation between offline and online pathways influences customer experience, installation services, and aftermarket support, with online channels accelerating initial procurement but offline channels often remaining critical for complex device installation and training.

Regional considerations that shape commercialization, regulatory strategy, and supply chain choices across the Americas, Europe Middle East Africa, and Asia Pacific markets

Regional dynamics materially influence demand drivers, regulatory requirements, and go-to-market execution for connected medical devices. In the Americas, mature reimbursement landscapes, advanced hospital infrastructure, and a strong appetite for remote monitoring combine to favor devices that demonstrate clear value in reducing acute care utilization. The region also features a dense network of private and public payers, which can accelerate adoption of devices that align with chronic disease management and post-acute care pathways. Meanwhile, supply chain logistics and proximity to component suppliers make the Americas a focal point for nearshoring and rapid product iterations.

Europe, Middle East & Africa present a heterogeneous environment where regulatory harmonization efforts coexist with divergent procurement models. In many European markets, centralized purchasing and health technology assessment processes require robust clinical and economic evidence, while Middle Eastern and African markets may present high-growth pockets driven by private hospital expansion and investment in digital health infrastructure. Across this region, data protection standards and interoperability initiatives influence device design and cloud architecture decisions, necessitating adaptable regulatory strategies and localized support models.

Asia-Pacific exhibits a broad spectrum of maturity, from advanced markets with strong domestic manufacturing ecosystems to rapidly developing healthcare systems that leapfrog legacy infrastructure through digital-first deployments. The region's scale and diversity create opportunities for scalable, lower-cost device variants and modular platforms that can be customized to local clinical needs. Additionally, the availability of contract manufacturers and electronics suppliers supports cost optimization strategies, while evolving reimbursement frameworks and large patient populations present fertile ground for remote monitoring and telehealth solutions. Taken together, regional insights underscore the need for differentiated commercialization strategies that align evidence generation, supply chain design, and partnership ecosystems to local market realities.

Analysis of incumbent and challenger company strategies highlighting platformization, partnerships, and evidence-driven commercialization to scale connected device offerings

Leading companies in the connected medical device arena demonstrate consistent patterns: integration of software and services into their core offerings, prioritization of cybersecurity and regulatory compliance, and cultivation of ecosystem partnerships to extend clinical reach. Market leaders invest in modular platforms that enable rapid feature deployment and third-party integrations, while maintaining rigorous change-management processes for software updates and post-market surveillance. Their R&D approaches emphasize clinical collaboration, pilot deployments with health systems, and iterative validation to build clinician trust and reimbursement pathways.

Smaller and mid-sized firms often compete by focusing on niche clinical problems, leveraging agility to iterate user interfaces and accelerate time-to-market. These organizations commonly pursue partnerships with cloud and analytics providers to supplement internal capabilities, and they target partnerships with channel distributors or health systems to secure initial scale. Many such firms adopt hybrid business models that combine device sales with recurring revenue from analytics subscriptions, remote monitoring services, or consumable components.

Across the competitive landscape, there is a growing trend of strategic alliances between traditional device manufacturers and digital health specialists. These collaborations accelerate access to data science capabilities, patient engagement tools, and population health platforms. At the same time, cross-industry entrants emphasize speed and experience design but must rapidly develop clinical validation processes and regulatory expertise to compete sustainably. Collectively, these company-level behaviors reveal a competitive imperative: integrate clinical evidence, robust cybersecurity, and partnership-driven distribution to scale effectively in complex care environments.

Practical strategic moves for manufacturers and providers to fortify product development, supply chain resilience, and go-to-market models for connected devices

Industry leaders should adopt a three-pronged approach that aligns product strategy, operational resilience, and market engagement to capture long-term value from connected medical devices. First, embed regulatory and clinical evidence planning at the earliest stages of product development so that software iterations, algorithm updates, and hardware revisions proceed with minimal downstream friction. Proactive planning reduces time to market for new capabilities and strengthens payor dialogues when outcomes data becomes available.

Second, redesign supply chain and sourcing strategies to increase resilience against trade disruptions and tariff-induced cost pressures. This includes diversifying component suppliers, qualifying alternate materials where feasible, and evaluating nearshoring for critical assemblies. Simultaneously, align procurement contracts to include flexibility clauses for tariff pass-throughs and establish strategic inventory buffers for key components that face volatile trade exposure.

Third, prioritize interoperability, cybersecurity, and user-centered design to accelerate adoption across care settings. Invest in open APIs, standards-based data models, and rigorous penetration testing, while conducting clinician-centered usability studies that minimize training burdens. In parallel, develop commercial models that blend capital equipment sales with subscription services, enabling predictable revenue while offering customers lower upfront costs.

Finally, cultivate strategic partnerships with payors, health systems, and technology providers to co-develop reimbursement pathways and integrated care programs. Use pilot deployments to gather real-world evidence that supports reimbursement negotiations and expands clinical indications. Executed together, these recommendations position organizations to reduce operational risk, enhance product-market fit, and convert connected device capabilities into durable commercial advantage.

Transparent research approach combining stakeholder interviews, technical assessments, regulatory reviews, and scenario testing to validate connected device insights

The research synthesis underpinning this analysis integrates primary stakeholder interviews, technical product assessments, policy and regulatory reviews, and secondary literature synthesis to produce a holistic view of the connected medical device landscape. Primary inputs included structured interviews with clinicians, procurement officers, regulatory specialists, and device engineers to ground insights in operational realities and evidence needs. These conversations were complemented by technical assessments of representative device architectures, connectivity stacks, and cybersecurity postures to surface recurring engineering constraints and integration patterns.

Regulatory and policy review processes examined current guidance on software as a medical device, cybersecurity requirements, and trade measures affecting medical technology supply chains. This review was paired with a comparative analysis of regional procurement mechanisms and reimbursement frameworks to assess how evidence thresholds and purchasing behaviors differ across markets. Secondary literature and public filings were analyzed to validate company strategies and to triangulate industry trends, while case studies of successful pilot deployments were used to illustrate pathways to scale.

Analytical methodologies combined qualitative thematic coding with scenario-based stress testing to evaluate sensitivity to tariff changes, connectivity shifts, and regulatory updates. Where applicable, evidence hierarchies were applied to weigh clinical studies, pilot outcomes, and real-world performance data. Throughout, transparency in assumptions and source provenance was maintained to enable reproducibility and to support client follow-up questions for deeper dives into specific product or regional nuances.

Concluding perspective on the systemic requirements for translating connected medical device innovation into durable clinical value and commercial success

Connected medical devices represent a pivotal frontier in healthcare transformation, offering pathways to earlier diagnosis, continuous chronic disease management, and more efficient use of clinical capacity. The confluence of advanced sensing, embedded software, and pervasive connectivity has created new expectations for product design, evidence generation, and post-market stewardship. Organizations that synchronize clinical validation, cybersecurity, and interoperability with resilient supply chains will be better positioned to scale and sustain market advantage.

Yet the path forward is complex. Tariff actions and trade uncertainty compel firms to reassess sourcing strategies and cost structures, while evolving regulatory and reimbursement landscapes require disciplined evidence planning. Market leaders are responding by platformizing offerings, forging strategic partnerships, and investing in real-world performance evidence that supports clinician adoption and payer coverage. Success will hinge on an integrated approach that aligns product development, operations, and go-to-market execution around measurable clinical and economic outcomes.

In closing, the institutions that treat connected devices as systems-where hardware, software, clinical workflows, and commercial models are co-designed-will unlock the greatest value. Those that apply rigorous risk management to supply chains and regulatory pathways, while maintaining a relentless focus on user needs and data quality, will convert technological promise into sustained clinical impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Connected Medical Devices Market, by Product Type

  • 8.1. Diagnostic Devices
    • 8.1.1. Imaging Systems
    • 8.1.2. Point Of Care Test Kits
    • 8.1.3. Ultrasound Devices
  • 8.2. Monitoring Devices
    • 8.2.1. ECG Monitor
    • 8.2.2. Glucose Monitor
    • 8.2.3. Vital Signs Monitor
  • 8.3. Surgical Devices
    • 8.3.1. Electrosurgical Devices
    • 8.3.2. Endoscopic Devices
    • 8.3.3. Robotic Surgery Systems
  • 8.4. Therapeutic Devices
    • 8.4.1. Dialysis Systems
    • 8.4.2. Infusion Pumps
    • 8.4.3. Ventilators
  • 8.5. Wearable Devices
    • 8.5.1. Fitness Trackers
    • 8.5.2. Smart Watches

9. Connected Medical Devices Market, by Connectivity Technology

  • 9.1. Bluetooth
  • 9.2. Cellular
  • 9.3. NFC
  • 9.4. Wi Fi
  • 9.5. Zigbee

10. Connected Medical Devices Market, by End User

  • 10.1. Ambulatory Care Centers
  • 10.2. Clinics
  • 10.3. Diagnostic Centers
  • 10.4. Home Care Settings
    • 10.4.1. Elderly Care
    • 10.4.2. Post Operative Care
  • 10.5. Hospitals
    • 10.5.1. Private Hospitals
    • 10.5.2. Public Hospitals

11. Connected Medical Devices Market, by Application

  • 11.1. Drug Delivery
    • 11.1.1. Infusion Drug Delivery
    • 11.1.2. Inhalation Systems
    • 11.1.3. Injection Drug Delivery
  • 11.2. Imaging
    • 11.2.1. CT
    • 11.2.2. MRI
    • 11.2.3. Ultrasound Imaging
    • 11.2.4. X Ray
  • 11.3. Patient Monitoring
    • 11.3.1. Ambulatory Monitoring
    • 11.3.2. Critical Care Monitoring
    • 11.3.3. Remote Monitoring
  • 11.4. Rehabilitation
    • 11.4.1. Neurorehabilitation
    • 11.4.2. Occupational Therapy
    • 11.4.3. Physical Therapy
  • 11.5. Surgical Assistance
    • 11.5.1. Navigation Systems
    • 11.5.2. Robotic Assistance
  • 11.6. Telehealth
    • 11.6.1. Remote Diagnosis
    • 11.6.2. Remote Patient Monitoring
    • 11.6.3. Video Consultation

12. Connected Medical Devices Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Connected Medical Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Connected Medical Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Connected Medical Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Connected Medical Devices Market

17. China Connected Medical Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Apple Inc.
  • 18.7. Baxter International Inc.
  • 18.8. Becton Dickinson and Company
  • 18.9. Boston Scientific Corporation
  • 18.10. Dexcom Inc.
  • 18.11. Fitbit Inc.
  • 18.12. Fresenius Medical Care AG & Co. KGaA
  • 18.13. Garmin Ltd.
  • 18.14. GE Healthcare
  • 18.15. Honeywell International Inc.
  • 18.16. iHealth Labs Inc.
  • 18.17. Insulet Corporation
  • 18.18. Johnson & Johnson Services Inc.
  • 18.19. Masimo Corporation
  • 18.20. Medtronic plc
  • 18.21. Omron Healthcare Inc.
  • 18.22. Philips Healthcare
  • 18.23. ResMed Inc.
  • 18.24. Roche Diagnostics
  • 18.25. Samsung Electronics Co. Ltd.
  • 18.26. Siemens Healthineers AG
  • 18.27. Smiths Medical
  • 18.28. Stryker Corporation
  • 18.29. Zimmer Biomet Holdings Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CONNECTED MEDICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CONNECTED MEDICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES CONNECTED MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA CONNECTED MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE TEST KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE TEST KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE TEST KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ECG MONITOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ECG MONITOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ECG MONITOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC SURGERY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC SURGERY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC SURGERY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIALYSIS SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIALYSIS SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIALYSIS SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY FITNESS TRACKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY FITNESS TRACKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY FITNESS TRACKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SMART WATCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SMART WATCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SMART WATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY BLUETOOTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY BLUETOOTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY BLUETOOTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CELLULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CELLULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CELLULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NFC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NFC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NFC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WI FI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WI FI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WI FI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ZIGBEE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ZIGBEE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ZIGBEE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ELDERLY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ELDERLY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ELDERLY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY POST OPERATIVE CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY POST OPERATIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY POST OPERATIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INHALATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INHALATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INHALATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INJECTION DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INJECTION DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INJECTION DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY X RAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY X RAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY X RAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CRITICAL CARE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CRITICAL CARE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CRITICAL CARE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NEUROREHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NEUROREHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NEUROREHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY OCCUPATIONAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY OCCUPATIONAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY OCCUPATIONAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PHYSICAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PHYSICAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VIDEO CONSULTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VIDEO CONSULTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VIDEO CONSULTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 198. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 199. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 201. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 202. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 203. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 204. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 205. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 208. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 209. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 211. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 212. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 213. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 214. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 215. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, 2018-2032 (USD MILLION)
  • TABLE 216. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 220. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 222. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 224. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 228. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 230. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 232. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 234. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, 2018-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 236. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 240. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 242. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 244. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 246. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 250. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 252. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, 2018-2032 (USD MILLION)
  • TABLE 254. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 294. MIDDLE EAST CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 296. MIDDLE EAST CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 298. MIDDLE EAST CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 300. MIDDLE EAST CONNE